SunTen Phytotech
Taipei, T'ai-pei, Taiwan
About SunTen Phytotech
SunTen Phytotech Co., Ltd., an herbal-based biotechnology company, develops botanical medicines and functional dietary products. Its products include SB221, a mixture of traditional Chinese herbal extracts for the treatment and prevention of vascular endothelial dysfunction-related diseases; STA36, a botanical composition for the adjuvant treatment of chronic asthma; STD052, a partially purified herbal material for gastrointestinal, cardiovascular, and kidney diseases; and STD06, an active component for various skin disorders and wound healing.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2006)
- Website: suntenglobal.com
- Phone: 886 2 8227 8111
Industries & Categories
Biotechnology, Medical, Product Design
Canonical: https://fsome.com/organization/sunten-phytotech-2521019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.